医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
21期
46-47
,共2页
慢性病毒性乙型肝炎%乙肝肝硬化%IL-17
慢性病毒性乙型肝炎%乙肝肝硬化%IL-17
만성병독성을형간염%을간간경화%IL-17
Chronic viral hepatitis%Liver cir hosis%IL-17
目的:分析不同疾病发展阶段慢性乙型肝炎病毒(HBV)感染患者的外周血IL-17检测以及其临床意义。方法收集HBV感染相性慢性乙肝病患者共58例作为观察组,并选择同期在我:门诊体检的健康人58例作为对照组,检测并对比分析两组的外周血IL-17含量。结果慢性乙型肝炎和肝硬化组IL-17血清水平均高于健康对照组(<0.01),且肝硬化组亦高慢性乙型肝炎组(<0.01),另外,失代偿期肝硬化患者IL-17水平均高于代偿期肝硬化患者。结论 HBV感染相关性慢性肝病IL-17的表达参与了HBV感染以后的免疫应答,在感染HBV直至发展成为肝硬化的整个过程中具有一定的作用,因此,IL-17有望作为肝硬化抗纤维化治疗的靶点。
目的:分析不同疾病髮展階段慢性乙型肝炎病毒(HBV)感染患者的外週血IL-17檢測以及其臨床意義。方法收集HBV感染相性慢性乙肝病患者共58例作為觀察組,併選擇同期在我:門診體檢的健康人58例作為對照組,檢測併對比分析兩組的外週血IL-17含量。結果慢性乙型肝炎和肝硬化組IL-17血清水平均高于健康對照組(<0.01),且肝硬化組亦高慢性乙型肝炎組(<0.01),另外,失代償期肝硬化患者IL-17水平均高于代償期肝硬化患者。結論 HBV感染相關性慢性肝病IL-17的錶達參與瞭HBV感染以後的免疫應答,在感染HBV直至髮展成為肝硬化的整箇過程中具有一定的作用,因此,IL-17有望作為肝硬化抗纖維化治療的靶點。
목적:분석불동질병발전계단만성을형간염병독(HBV)감염환자적외주혈IL-17검측이급기림상의의。방법수집HBV감염상성만성을간병환자공58례작위관찰조,병선택동기재아:문진체검적건강인58례작위대조조,검측병대비분석량조적외주혈IL-17함량。결과만성을형간염화간경화조IL-17혈청수평균고우건강대조조(<0.01),차간경화조역고만성을형간염조(<0.01),령외,실대상기간경화환자IL-17수평균고우대상기간경화환자。결론 HBV감염상관성만성간병IL-17적표체삼여료HBV감염이후적면역응답,재감염HBV직지발전성위간경화적정개과정중구유일정적작용,인차,IL-17유망작위간경화항섬유화치료적파점。
Objective We analyze the IL-17 test of chronic hepatitis B virus(HBV) suf erers on every stage of the disease and it's clinical significance. Methods The col ection phase of chronic HBV infection in patients with a total of 58 cases of hepatitis B as the observation group, and select the same period in our clinic examination of 58 cases of healthy people as a control group, and comparative analysis of the two groups detected in peripheral blood IL-17 content. Results The IL-17 blood serum level of chronic HBV suf erers and cir hosis was higher than the healthy persons ( <0.01), meanwhile, the blood serum level of cirrhosis was higher than HBV ( <0.01). Moreover, patients with decompensated cir hosis IL-17 levels were higher in patients with decompensated cir hosis. Conclusion Expression of HBV-related chronic liver infection IL-17 are involved in the immune response after HBV infection, the explanations of IL-17 turn out to be ef ective while HBV develops into cir hosis. Hopeful y, the IL-17 test may thus be the bul 's eye of cri hosis antifibrotic therapy.